T
Taj For DoctorsTaj Doctor
home

About Us

Taj Brands

Diseases Health Tips  HIV/AIDS News Contact Us

 

  All News
  Allergy
  Asthma
  Cardiology
  Clinical Research
  Critical Care
  Dentistry
  Dermatology
  Endocrinology
  Gastroenterology
  General
  Genetics / Biotech
  Men's Health
  Infectious Diseases
  Fitness/Lifestyle
  Nephrology
  Neurology
  Oncology/Haematology
  Ophthalmology
  Orthopaedics
  Otolaryngology
  Paediatrics
  Psychiatry
  Reproductive Health
  Respiratory Medicine
  Surgery
  Sex
  Urology
  Women's Health
Taj Brands


Therapeutic Index

TOZOL-20

Each capsule (E.C. granules ) contains:


Composition:

Omeprazol..................................................................20 mg

 

Indications:

Ulcer, duodenal; Adenoma, multiple endocrine; Esophagitis, erosive; Gastroesophageal Reflux Disease; Mastocytosis, systemic; Ulcer, gastric; Zollinger-Ellison syndrome; Pregnancy Category C;

 

Description:

Omeprazole is a selective and irreversible proton pump inhibitor. Omeprazole suppresses gastric acid secretion by specific inhibition of the hydrogen–potassium adenosinetriphosphatase (H +, K +-ATPase) enzyme system found at the secretory surface of parietal cells. It inhibits the final transport of hydrogen ions (via exchange with potassium ions) into the gastric lumen. Since the H +, K +-ATPase enzyme system is regarded as the acid (proton) pump of the gastric mucosa, omeprazole is known as a gastric acid pump inhibitor. The inhibitory effect is dose-related. Omeprazole inhibits both basal and stimulated acid secretion irrespective of the stimulus.

 

Side/Adverse Effects


Note: Gastric fundic gland polyps have occurred rarely in patients receiving omeprazole; these appear to be benign and reversible upon discontinuance of omeprazole.
Gastroduodenal carcinoids have been reported in patients with Zollinger-Ellison syndrome who have received long-term omeprazole therapy. These carcinoids are believed to be a manifestation of the underlying syndrome, which is known to be associated with such tumors.
Atrophic gastritis has been noted occasionally in gastric corpus biopsies from patient receiving long-term omeprazole therapy.
Overt liver disease has occurred rarely, and included hepatocellular, cholestatic, or mixed hepatitis, liver necrosis (sometimes fatal), hepatic failure (sometimes fatal), and hepatic encephalopathy.
The following side/adverse effects have been selected on the basis of their potential clinical significance (possible signs and symptoms in parentheses where appropriate)—not necessarily inclusive:

 

Contraindications
Omeprazole delayed-release capsules are contraindicated in patients with known hypersensitivity to any component of the formulation

Dosage: As per the physician’s advice.

Presentations:                         10 caps       
                                                     MRP           Retailer     Stockiest
                                                    
9.80               7.84              7.05

 
 

         Copyright © 2004- 2006 TAJ Pharmaceuticals Limited. All Rights Reserved.

Site Requirements : Internet Explorer 5.0+ or Netscape 5.0+, Flash Player 5.0 & Real Player 8 Basic
To get in touch with us, call on 91-22-2637 4592, 91--22-2637 4593 or fax us at 91-22-2634 1274 

Terms and Conditions | Disclaimer | Privacy Policy | Sitemap | Feedback | FAQ